Simplify Logo

Full-Time

Associate Director

Quality Assurance, Gcp

Posted on 6/27/2024

Relay Therapeutics

Relay Therapeutics

201-500 employees

Biotech company focused on drug discovery

Biotechnology
Healthcare

Expert

Remote in USA

This is a remote position specific to GCP/GCLP/GVP sites, domestic and international.

Category
Public Health
Biology & Biotech
Required Skills
Google Cloud Platform
Requirements
  • Bachelor’s degree in a scientific field
  • Minimum of 10+ years of Quality Assurance/GCP/GCLP/GVP Operations experience in pharmaceutical or biotech industry
  • In-depth knowledge of GCP/GCLP/GVP and QA principles, practices, and standards; thorough understanding of FDA, MHRA, EMA and ICH quality regulations
Responsibilities
  • Serve as primary Quality contact for external clinical and patient safety vendors
  • Contribute to the development of Quality Management Systems
  • Review and approve GCP/GCLP/GVP documents
  • Create and execute risk-based clinical trial audit plans
  • Develop and implement inspection readiness strategy
  • Conduct internal audits and provide audit metrics
  • Develop and execute Quality Agreements with vendors
  • Interpret and manage quality investigations
  • Communicate with vendors to address activities
  • Contribute to the development of the Quality Management System
  • Provide Quality Assurance expertise and guidance to external CROs
  • Review GCP/GCLP/GVP documentation and regulatory submissions
  • Contribute to other areas of Quality Assurance as needed

Relay Therapeutics focuses on drug discovery by emphasizing the movement of proteins in its research. The company uses its Dynamo™ platform, which integrates experimental and computational methods, to identify and develop new drugs, particularly for complex diseases that are hard to treat with traditional approaches. This platform enables Relay to target proteins that have previously been difficult to address, expanding treatment options, especially in precision oncology and genetic diseases. Unlike its competitors, Relay Therapeutics collaborates with major biotech firms, such as Genentech, to validate its technology and generate revenue through licensing and partnerships. The main goal of Relay Therapeutics is to create impactful medicines for patients, and it is actively conducting clinical trials to ensure the safety and effectiveness of its drug candidates.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-12%

2 year growth

-5%
Simplify Jobs

Simplify's Take

What believers are saying

  • Relay's focus on precision oncology and genetic diseases positions it at the forefront of personalized medicine, offering significant growth potential.
  • Recent investments and financing, including a $30 million private placement and $400 million Series C financing, indicate strong financial backing and investor confidence.
  • Initial clinical data for RLY-2608 and other promising drug candidates highlight the company's potential for successful therapeutic developments.

What critics are saying

  • The highly competitive biotech sector requires continuous innovation to maintain a leading position.
  • Dependence on strategic partnerships and licensing agreements could pose risks if collaborations do not yield expected results.

What makes Relay Therapeutics unique

  • Relay Therapeutics places protein motion at the core of its drug discovery process, a unique approach that sets it apart from traditional methods.
  • The Dynamo™ platform combines experimental and computational techniques to target previously undruggable proteins, expanding treatment possibilities.
  • Strategic collaborations, such as the one with Genentech, validate the potential of Relay's innovative technology and approach.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, vision

Life, disability, & FSA

401k

Commuter benefits

Parental leave

Home office stipend

Tuition reimbursement

PTO

INACTIVE